EUVIMEDEUVIMED entdecken
Open Access

Transcriptomic Analysis of the Amygdala in Subjects with Schizophrenia, Bipolar Disorder and Major Depressive Disorder Reveals Differentially Altered Metabolic Pathways

Xiaolu Zhang, Jake Valeri, Mahmoud A Eladawi iD, Barbara Gisabella, Michael R Garrett, Eric J Vallender, Robert McCullumsmith, Harry Pantazopoulos, Sinead M O'Donovan iD

Schizophrenia Bulletin · 2026

DOI: 10.1093/schbul/sbae193 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Schizophrenia Bulletin, 2026. Verfasst von Xiaolu Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Louisiana State University Health Sciences Center, Shreveport, LA 70112, United States. Hauptthemen laut MEDLINE: Bipolar Disorder, Schizophrenia, Major Depressive Disorder, Amygdala. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, Obesity, Cardiorenal and Metabolic Diseases-COBRE, Baszucki Brain Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Hypothesis The amygdala, crucial for mood, anxiety, fear, and reward regulation, shows neuroanatomical and molecular divergence in psychiatric disorders like schizophrenia, bipolar disorder and major depression. This region is also emerging as an important regulator of metabolic and immune pathways. The goal of this study is to address the paucity of molecular studies in the human amygdala. We hypothesize that diagnosis-specific gene expression alterations contribute to the unique pathophysiological profiles of these disorders. Study Design We used a cohort of subjects diagnosed with SCZ, BPD or MDD, and nonpsychiatrically ill control subjects (n = 15/group), together with our bioinformatic 3-pod analysis consisting of full transcriptome pathway analysis, targeted pathway analysis, leading-edge gene analysis and iLINCS perturbagen analysis. Study Results We identified altered expression of metabolic pathways in each disorder. Subjects with SCZ displayed downregulation of mitochondrial respiration and nucleotide metabolism pathways. In comparison, we observed upregulation of mitochondrial respiration pathways in subjects with MDD, while subjects with BPD displayed enrichment of pathways involved in carbohydrate metabolism. Several pathways associated with brain metabolism including immune system processes and calcium ion transport were also differentially altered between diagnosis groups. Conclusion Our findings suggest metabolic pathways, including downregulation of energy metabolism pathways in SCZ and upregulation of energy metabolism pathways in MDD, are uniquely altered in the amygdala in these disorders, which may impact approaches for therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bipolar DisorderSchizophreniaMajor Depressive DisorderAmygdalaMetabolic Networks and PathwaysTranscriptomeHumansAdultMaleFemaleGene Expression ProfilingMiddle Aged

Stichwörter der Autor:innen

energy metabolismpostmortem brain tissuepsychiatric disordertranscriptome

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Louisiana State University Health Sciences Center, Shreveport, LA 70112, United States.
  • Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, MS 39216, United States.
  • Program in Neuroscience, University of Mississippi Medical Center, Jackson, MS 39216, United States.
  • Department of Neurosciences, University of Toledo, Toledo, OH 43614, United States.
  • Department of Cell and Molecular Biology, University of Mississippi Medical Center, Jackson, MS 39216, United States.
  • Promedica Neuroscience Institute, Toledo, OH 43606, United States.

ORCID-Profile: Mahmoud A Eladawi, Sinead M O'Donovan

Förderung

  • NIGMS NIH HHS
  • Obesity, Cardiorenal and Metabolic Diseases-COBRE
  • Baszucki Brain Research Foundation
  • American Foundation for Suicide Prevention
  • Molecular Center of Health and Disease
  • National Institute of General Medical Sciences

Zitieren

APA

Zhang, X., Valeri, J., Eladawi, M. A., Gisabella, B., Garrett, M. R., Vallender, E. J., McCullumsmith, R., Pantazopoulos, H., & O'Donovan, S. M. (2026). Transcriptomic Analysis of the Amygdala in Subjects with Schizophrenia, Bipolar Disorder and Major Depressive Disorder Reveals Differentially Altered Metabolic Pathways. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbae193

Vancouver

Zhang X, Valeri J, Eladawi MA, Gisabella B, Garrett MR, Vallender EJ, et al. Transcriptomic Analysis of the Amygdala in Subjects with Schizophrenia, Bipolar Disorder and Major Depressive Disorder Reveals Differentially Altered Metabolic Pathways. Schizophrenia Bulletin. 2026. doi:10.1093/schbul/sbae193

BibTeX
@article{Zhang2026,
  author = {Zhang, Xiaolu and Valeri, Jake and Eladawi, Mahmoud A and Gisabella, Barbara and Garrett, Michael R and Vallender, Eric J and McCullumsmith, Robert and Pantazopoulos, Harry and O'Donovan, Sinead M},
  title = {Transcriptomic Analysis of the Amygdala in Subjects with Schizophrenia, Bipolar Disorder and Major Depressive Disorder Reveals Differentially Altered Metabolic Pathways},
  journal = {Schizophrenia Bulletin},
  year = {2026},
  doi = {10.1093/schbul/sbae193}
}
Kostenlos starten →